What are the precautions to be taken
[21] Onakpoya I, Hung SK, Perry R, et al
GHRP-2 is a more potent second-generation analog
(Note: A similarly named but unrelated Vitals RX did receive an FDA warning letter in September 2025, but it is not the same pharmacy.) Additionally, Belle received an FDA warning letter in February of 2026 and was cited for misbranding after putting Belle labels on compounded GLP-1s
Unfortunately, due to the limited number of studies available, we could not provide a detailed subgroup analysis based on the specific GLP-1RAs classifications, procedure type, baseline patient characteristics, and the timing of therapy initiation